Top Markets
Coin of the day
BioGend Therapeutics Co., Ltd. BioGend Therapeutics Co., Ltd.

BioGend Therapeutics Co., Ltd.

6733
Rank in Stocks #21371
This company specializes in the development of innovative regenerative... This company specializes in the development of innovative regenerative bio-orthopedic products. Its current pipeline includes BiG-001 and BiG-006, both of which are osteoinductive bone graft substitutes. Additionally, it is advancing BiG-009, an autologous cartilage repair system. Established in 2016, the firm's operations are based in Taipei, Taiwan.
Share Price
$0.81882497
Last synced: 2026-08-21
Market Cap
$108.85M
Change (1 day)
0.39%
Change (1 year)
-38.35%
Country
TW
Trade BioGend Therapeutics Co., Ltd. (6733)

Category

EPS for BioGend Therapeutics Co., Ltd. (6733)
EPS as of 2026 TTM: 0
According to BioGend Therapeutics Co., Ltd. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for BioGend Therapeutics Co., Ltd. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH